Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, April 10, 2024

Nobel-winning biologist on the most promising ways to stop ageing

 FYI.

Nobel-winning biologist on the most promising ways to stop ageing

Efforts to extend our lifespan continue and many look promising, but success will have unintended consequences, says Nobel prizewinner Venki Ramakrishnan


By Graham Lawton

18 March 2024New Scientist Default Image

Ula Šveikauskaitė

ANTI-AGEING is big business. From books encouraging diets such as intermittent fasting to cosmetic creams to combat wrinkles, a multibillion-dollar industry has been built on promises to make us live longer and look younger. But how close are we really to extending our lifespan in a way that gives us extra years of healthy life?

Nobel prizewinner Venki Ramakrishnan, a molecular biologist and former president of the UK’s Royal Society, is the latest to tackle this question. He has spent 25 years studying the ribosome, which is where our cells make proteins using the information encoded in our genes, at the MRC Laboratory of Molecular Biology in Cambridge, UK.

In his latest book, Why We Die: The new science of ageing and the quest for immortality, he goes on a journey around the cutting-edge biology of human ageing and asks whether it will be possible to extend our lifespan in the near future.

He talks to New Scientist about the recent breakthroughs in our knowledge of what causes ageing, how close we are to creating therapeutics to combat it, and the potential consequences if we succeed.

Graham Lawton: What inspired you to take a break from a hugely successful career researching how cells make proteins to write a book about ageing?

Venki Ramakrishnan: Two things. One is that the translation of genetic code into proteins affects almost every biological process, and it turns out to be central to many aspects of ageing.

The other reason is that we have worried about ageing and death ever since we…

To continue reading, subscribe today with our introductory offers

about the recent breakthroughs in our knowledge of what causes ageing, how close we are to creating therapeutics to combat it, and the potential consequences if we succeed.

Graham Lawton: What inspired you to take a break from a hugely successful career researching how cells make proteins to write a book about ageing?

Venki Ramakrishnan: Two things. One is that the translation of genetic code into proteins affects almost every biological process, and it turns out to be central to many aspects of ageing.

The other reason is that we have worried about ageing and death ever since we…

To continue reading, subscribe today with our introductory offers

No comments:

Post a Comment